Gustaf Wiklund

Associate, Stockholm

Biography

Overview

Gustaf Wiklund is a senior associate in our Capital Markets practice in Stockholm.

Gustaf is proving himself highly valuable to and appreciated by clients and other stakeholders alike. He has a significant track record of advising domestic and international issuers, owners, sponsors and underwriters, as well as other categories of clients, on a variety of capital markets transactions. These include numerous major Nordic and U.S. IPOs, dual-listings, rights issues, ABBs and private placements, as well as public M&A transactions, such as domestic and cross-border buy-outs. He also advises several listed companies on various corporate governance related matters, including in relation to general meetings, compliance and incentive programs, and has experience from advising both listed companies and activist funds on shareholder activism and public defence.

Bars and Courts
Swedish Bar
Education
LLM
Master of Laws
Gothenburg School of Business
Economics and Law, Sweden
Languages
Swedish
English

Experience

Representation of Pierce Group in connection with its SEK 347 million rights issue.

Representation of EQT, a leading global investment firm, on:

  • Karo Pharma, a consumer healthcare company and a portfolio company of EQT, on its SEK 2.5 billion rights issue and Nasdaq First North Growth Market listing of Karo Pharma.
  • Karo Pharma on the SEK 6.2 billion public cash offer to the shareholders.
  • Karo Pharma on its EUR 300 million acquisition of Sylphar from private equity firm Vendis Capital and Robin List, Sylphar's founder.
  • Karo Pharma on its fully underwritten SEK 2.0 billion rights issue.
  • their dual track exit of Piab, a leader in industrial vacuum-based automation and robot components, resulting in the sale to Investor AB (publ) (Patricia Industries) for an enterprise value of SEK 7.0 billion.

Representation of ABG Sundal Collier and Berenberg in connection with the SEK 452 million initial public offering (IPO) and Nasdaq First North Premier Growth Market listing of 4C Strategies.

Representation of Valedo and Norva24 in connection with the SEK 6.9 billion initial public offering (IPO) and Nasdaq Stockholm listing of Norva24.

Representation of IK Partners in connection with the divestment of BST Brandskyddsteamet to Norvestor.

Representation of Cary Group and Nordic Capital in connection with the SEK 9.2 billion initial public offering (IPO) and Nasdaq Stockholm listing of Cary Group.

Representation of Kjell Group and FSN Capital in connection with the SEK 1.7 billion initial public offering (IPO) and Nasdaq First North Growth Market listing of Kjell Group.

Representation of Oatly in connection with its USD 10 billion initial public offering (IPO) and New York listing on the Nasdaq Global Select Market.

Representation of Carnegie Investment Bank, a financial services group, as sole global coordinator and joint bookrunner and Swedbank, a Nordic-Baltic banking group, as joint bookrunner in connection with the EUR 64 million IPO and Nasdaq Helsinki listing of Optomed, a health care technology company.

Representation of Jefferies, Carnegie, DNB, Cowen and Kempen, all financial services firms, as the joint global coordinators and placement agents in connection with the SEK 727 million private placement of shares in Oncopeptides, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat haematological diseases.

Representation of Carnegie and Nordea, both financial services groups, in connection with the SEK 4.2 billion IPO and Nasdaq Stockholm listing of Karnov Group, a provider of information and advisory.

Representation of Bridgepoint, a private equity firm, and European Entertainment Intressenter BidCo AB, an investment firm, on the SEK 9.2 billion public cash offer to the shareholders of Cherry, one of Scandinavia's oldest gaming companies.

Representation of Jefferies, Carnegie and DNB, all financial services firms, as the joint bookrunners and placement agents in connection with the SEK 546 million private placement of shares in Oncopeptides, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat haematological diseases.

Representation of Deutsche Bank and Nordea, both financial services firms, as the joint bookrunners and placement agents in connection with the SEK 568 million private placement of shares in Hoist Finance, a Swedish financial services company.

Representation of Arion Banki, a leading universal relationship bank in Iceland, and Kaupthing, an Icelandic bank, in connection with the SEK 3.2 billion IPO and dual-listing in Stockholm and Reykjavik of Arion Bank.

Representation of Projektengagemang, a civil engineering consulting firm, and its founders in connection with the 470 million IPO and Nasdaq Stockholm listing of Projektengagemang.

Representation of Ovzon, a broadband telecommunication company offering mobile communication services via satellite, and its founders in connection with the SEK 325 million IPO and Nasdaq First North Premier listing of Ovzon.

Representation of DNB, Swedbank and Crédit Agricole, all financial services firms, as placement agents in connection with the SEK 508 million private placement of shares in Recipharm, a pharmaceutical contract development and manufacturing organisation.

Representation of Handicare, a leading manufacturer of solutions and medical equipment for disabled and elderly people, and its principal shareholder Nordic Capital, a leading private equity firm in the Nordic region, in connection with the SEK 854.6 million IPO and Nasdaq Stockholm listing of Handicare.

Representation of Carnegie, Goldman Sachs, Danske Bank, Jefferies, Nordea, and Swedbank, all financial services firms, as underwriters in connection with the SEK 4.0 billion IPO and Nasdaq Stockholm listing of Munters, a global provider of energy efficient air treatment systems.

Representation of Carnegie, Danske Bank and Berenberg, both financial services institutions, as underwriters in connection with the SEK 1.6 billion IPO and Nasdaq Stockholm listing of Boozt, a leading on-line retailer.

Representation of ABG Sundal Collier, Carnegie and DNB, all financial services institutions, as underwriters in connection with the SEK 650 million IPO and Nasdaq Stockholm listing of Oncopeptides, a research and development stage pharmaceutical company developing drugs for treat of cancer.